arrow
R

Rudi Balling

Luxembourg Centre for Systems Biomedicine
H指数:85
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Systems medicine disease maps: community-driven comprehensive representation of disease mechanisms

作者更正:系统医学疾病图谱:社区驱动的疾病机制全面表征

2025-07-120
OA
Author Correction: Mitochondria interaction networks show altered topological patterns in Parkinson’s disease

作者更正:线粒体相互作用网络在帕金森病中显示出改变的拓扑模式

2025-07-030
OA
Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches
2024-02-131
OAAI
Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson's study

在卢森堡帕金森研究中,准确的长读测序将GBA1确定为主要危险因素

2023-11-238
OAAI
Early-to-mid stage idiopathic Parkinson's disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females

早期至中期特发性帕金森病显示女性CD8 T细胞的细胞毒性和分化增强

2023-11-209
OAAI
PARK7/DJ-1 promotes pyruvate dehydrogenase activity and maintains Treg homeostasis during ageing
2022-05-2625
OA
Neurodegeneration and neuroinflammation are linked, but independent of alpha-synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease

在帕金森病的播种/扩散小鼠模型中,神经变性和神经炎症是相关的,但独立于 α-突触核蛋白包涵体

GLIA
IF5.1
2022-01-2936
OAAI
DJ-1 depletion prevents immunoaging in T-cell compartments

DJ-1耗竭可防止T细胞区室的免疫老化

2022-01-178
OA
COVID-19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms (vol 17, e10387, 2021)

新型冠状病毒肺炎疾病图谱,病毒-宿主相互作用机制的计算知识库 (第17卷,e10387,2021)

2021-12-2349
OAAI
COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms

COVID19疾病图谱,病毒-宿主相互作用机制的计算知识库

2021-10-1949
OAAI
Towards a European strategy to address the COVID-19 pandemic
LANCET
IF88.5
2021-09-0134
OAAI
Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson's disease progression
2021-03-1529
OAAI
AsthmaMap: An interactive knowledge repository for mechanisms of asthma

AsthmaMap: 哮喘机制的交互式知识库

2021-03-017
OAAI
An action plan for pan-European defence against new SARS-CoV-2 variants
LANCET
IF88.5
2021-02-0185
OAAI